BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31897993)

  • 1. PET-derived bone information from 18F-sodium fluoride: A perfect match for whole-body PET/MR attenuation correction?
    Lassen ML; Slomka PJ
    J Nucl Cardiol; 2020 Aug; 27(4):1142-1144. PubMed ID: 31897993
    [No Abstract]   [Full Text] [Related]  

  • 2. Hybrid PET- and MR-driven attenuation correction for enhanced
    Karakatsanis NA; Abgral R; Trivieri MG; Dweck MR; Robson PM; Calcagno C; Boeykens G; Senders ML; Mulder WJM; Tsoumpas C; Fayad ZA
    J Nucl Cardiol; 2020 Aug; 27(4):1126-1141. PubMed ID: 31667675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions.
    Robson PM; Dweck MR; Trivieri MG; Abgral R; Karakatsanis NA; Contreras J; Gidwani U; Narula JP; Fuster V; Kovacic JC; Fayad ZA
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1103-1112. PubMed ID: 28109921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of quantification errors in pelvic and spinal lesions caused by ignoring higher photon attenuation of bone in [18F]NaF PET/MR.
    Schramm G; Maus J; Hofheinz F; Petr J; Lougovski A; Beuthien-Baumann B; Oehme L; Platzek I; van den Hoff J
    Med Phys; 2015 Nov; 42(11):6468-76. PubMed ID: 26520736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous [18F]fluoride and gadobutrol enhanced coronary positron emission tomography/magnetic resonance imaging for in vivo plaque characterization.
    Wurster TH; Landmesser U; Abdelwahed YS; Skurk C; Morguet A; Leistner DM; Fröhlich G; Haghikia A; Engel LC; Schuster A; Noutsias M; Schulze D; Hamm B; Furth C; Brenner W; Botnar RM; Bigalke B; Makowski MR
    Eur Heart J Cardiovasc Imaging; 2022 Sep; 23(10):1391-1398. PubMed ID: 35015852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-Body PET/MR Imaging: Quantitative Evaluation of a Novel Model-Based MR Attenuation Correction Method Including Bone.
    Paulus DH; Quick HH; Geppert C; Fenchel M; Zhan Y; Hermosillo G; Faul D; Boada F; Friedman KP; Koesters T
    J Nucl Med; 2015 Jul; 56(7):1061-6. PubMed ID: 26025957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Significance of 18F-FDG PET/CT Imaging Coupled with Magnetic Resonance Imaging of the Entire Body for Bone Metastases.
    Guo H; Zhang Z; Wang L; Yao S; Xu S; Ma S; Liu S
    Contrast Media Mol Imaging; 2022; 2022():7717398. PubMed ID: 36247843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorodeoxyglucose positron emission tomography/magnetic resonance imaging: current status, future aspects.
    Rakheja R; Chandarana H; Ponzo F; Seltzer AL; Beltran LS; Geppert C; Friedman KP
    PET Clin; 2014 Apr; 9(2):237-52. PubMed ID: 25030285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance-based attenuation correction for PET/MR hybrid imaging using continuous valued attenuation maps.
    Navalpakkam BK; Braun H; Kuwert T; Quick HH
    Invest Radiol; 2013 May; 48(5):323-32. PubMed ID: 23442772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 18F-fluoride PET/MR and PET/CT in patients with foot pain of unclear cause.
    Rauscher I; Beer AJ; Schaeffeler C; Souvatzoglou M; Crönlein M; Kirchhoff C; Sandmann G; Fürst S; Kilger R; Herz M; Ziegler S; Schwaiger M; Eiber M
    J Nucl Med; 2015 Mar; 56(3):430-5. PubMed ID: 25678485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous PET/MR body imaging in rats: initial experiences with an integrated PET/MRI scanner.
    Tatsumi M; Yamamoto S; Imaizumi M; Watabe T; Kanai Y; Aoki M; Kato H; Shimosegawa E; Hatazawa J
    Ann Nucl Med; 2012 Jun; 26(5):444-9. PubMed ID: 22359223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.
    Avery R; Kuo PH
    Clin Nucl Med; 2013 Sep; 38(9):746-8. PubMed ID: 23797230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
    Zamagni E; Nanni C; Patriarca F; Englaro E; Castellucci P; Geatti O; Tosi P; Tacchetti P; Cangini D; Perrone G; Ceccolini M; Brioli A; Buttignol S; Fanin R; Salizzoni E; Baccarani M; Fanti S; Cavo M
    Haematologica; 2007 Jan; 92(1):50-5. PubMed ID: 17229635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Assessment of Emission- and Segmentation-Based MR-Guided Attenuation Correction in Whole-Body Time-of-Flight PET/MR Imaging.
    Mehranian A; Zaidi H
    J Nucl Med; 2015 Jun; 56(6):877-83. PubMed ID: 25858043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[
    Sonni I; Minamimoto R; Baratto L; Gambhir SS; Loening AM; Vasanawala SS; Iagaru A
    Mol Imaging Biol; 2020 Apr; 22(2):397-406. PubMed ID: 31236756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone scanning with sodium 18F-fluoride PET and PET/CT. German guideline Version 1.0.].
    Hellwig D; Krause BJ; Schirrmeister H; Freesmeyer M
    Nuklearmedizin; 2010; 49(5):195-201. PubMed ID: 20838734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Alexanderson-Rosas E; Monroy-Gonzalez AG; Juarez-Orozco LE; Martinez-Aguilar MM; Estrada E; Soldevilla I; Garcia-Pérez O; Soto-Lopez ME
    J Nucl Cardiol; 2017 Oct; 24(5):1674-1679. PubMed ID: 27506703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.